We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$33B
AUM Growth
-$595M
Cap. Flow
-$2.78B
Cap. Flow %
-8.43%
Top 10 Hldgs %
36.74%
Holding
117
New
22
Increased
30
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$974M
2
JD icon
JD.com
JD
+$620M
3
FIGS icon
FIGS
FIGS
+$559M
4
COUP
Coupa Software Incorporated
COUP
+$447M
5
GE icon
GE Aerospace
GE
+$417M

Sector Composition

Rank Sector Weight
1 Healthcare 34.71%
2 Technology 23.68%
3 Financials 11.86%
4 Consumer Discretionary 11.43%
5 Industrials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
76
Pacific Biosciences
PACB
$354M
$44.5M 0.14%
1,273,659
+980,324
+334% +$28.5M
PHVS icon
77
Pharvaris
PHVS
$2.41B
$43.5M 0.13%
2,391,517
-28,638
-1% -$650K
KNTE
78
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$42.4M 0.13%
1,820,462
-51,561
-3% -$1.31M
MUDS
79
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$38M 0.12%
+3,048,405
New +$39.7M
OHPAU
80
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$35.7M 0.11%
3,597,342
-39,881
-1% -$398K
BILI icon
81
Bilibili
BILI
$7.53B
$32.5M 0.1%
266,483
-196,876
-42% -$21.3M
DAWN
82
DELISTED
Day One Biopharmaceuticals
DAWN
$30.5M 0.09%
+1,341,396
New +$28M
XLRN
83
DELISTED
Acceleron Pharma
XLRN
$24.6M 0.07%
+196,136
New +$24.7M
BZ icon
84
Kanzhun
BZ
$7.49B
$21.6M 0.07%
+545,726
New +$21M
GRCL
85
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$17.3M 0.05%
1,330,328
-14,748
-1% -$197K
EM
86
DELISTED
Smart Share Global Ltd
EM
$2.85M 0.01%
+470,000
New +$3.33M
BNT
87
Brookfield Wealth Solutions
BNT
$12.4B
$1.25M ﹤0.01%
+36,116
New +$1.37M
ABCL icon
88
AbCellera Biologics
ABCL
$2.98B
-19,083,744
Closed -$648M
AFRM icon
89
Affirm
AFRM
$25.7B
-250,000
Closed -$17.7M
ALHC icon
90
Alignment Healthcare
ALHC
$2.74B
-625,038
Closed -$13.7M
ANET icon
91
Arista Networks
ANET
$250B
-72,992
Closed -$1.38M
LONA
92
LeonaBio Inc
LONA
$71.6M
-212,065
Closed -$39M
BMBL icon
93
Bumble
BMBL
$367M
-1,118,983
Closed -$69.8M
BPMC
94
DELISTED
Blueprint Medicines
BPMC
-213,050
Closed -$20.7M
CI icon
95
Cigna
CI
$72.4B
-579,029
Closed -$140M
DPZ icon
96
Domino's
DPZ
$11.8B
-74,568
Closed -$27.4M
EQH icon
97
Equitable Holdings
EQH
$14B
-5,987,489
Closed -$195M
HCA icon
98
HCA Healthcare
HCA
$89.1B
-1,498,742
Closed -$282M
HIG icon
99
Hartford Financial Services
HIG
$38.1B
-2,552,300
Closed -$170M
JPM icon
100
JPMorgan Chase
JPM
$962B
-874,417
Closed -$133M

Similar funds

Viking Global Investors's Q2 2021 Portfolio in Review

As of Q2 2021, Viking Global Investors held 117 positions worth $33B, down 1.8% from $33.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Viking Global Investors withdrew a net $2.78B in Q2 2021, closing 29 positions and reducing 29 holdings. Its most notable exit was AbCellera Biologics, an estimated $648M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

Against the trend, Viking Global Investors opened a new position in JD.com worth $658M.

  • Viking Global Investors's largest Q2 2021 buy was JD.com: 8,241,079 shares worth $658M.
  • Viking Global Investors added most to Amazon in Q2 2021, an estimated $974M increase.
  • Viking Global Investors's biggest Q2 2021 reduction was Bank of America, cutting an estimated $989M.
  • Viking Global Investors fully exited AbCellera Biologics in Q2 2021, selling an estimated $648M.
  • Viking Global Investors's ten largest holdings make up 37% of its $33B portfolio in Q2 2021.
  • Viking Global Investors opened 22 new positions and closed 29 in Q2 2021.
  • Viking Global Investors's portfolio value fell 1.8% quarter-over-quarter to $33B.

Based on Viking Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.